Muralidharan KK, Karumanchi S, Kowalski KG, Burkett P, Chapel S, Rajagovindan R, Nestorov I. A Time-to-Event Exposure-Response Model for Amyloid-Related Imaging Abnormalities Following Administration of Aducanumab to Subjects With Early Alzheimer Disease. J Clin Pharmacol. 2022 Aug;62(8):1030-1046. Epub 2022 Apr 4 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.